Search

Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working. We get the story behind their facility in Petersburg.

The deadline for the US Drug Supply Chain Security Act is approaching.

Our special series eBook covers some of the hottest topics in cell and gene therapy including closed processing and more.

The search for an effective treatment for childhood brain cancers goes on, but a modified Herpes virus could represent a breakthrough.

Drug shortages are everywhere. We speak with Vimala Raghavendran at the US Pharmacopeia to get the full picture.

Vaccine manufacturers invited to take on mpox challenges

With open minds and open sources, the future is foundational – and bright.

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.

We get the background on a new manufacturing platform for cell and gene therapy from Ori Biotech, tested by MD Anderson and Resilience’s CTMC.

We speak with the Alzheimer’s Society in the UK about their work. Find out more with The Medicine Maker